SEC Filings
Stryker Adds A Board Seat For Quest Diagnostics Leader James E. Davis
Davis previously ran InSightec and GE's MRI business; his Stryker board service is scheduled to begin January 1, 2027.
Stryker (SYK) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
Davis previously ran InSightec and GE's MRI business; his Stryker board service is scheduled to begin January 1, 2027.
SEC Filings
Stryker's 10-Q shows a 100-basis-point rise in the discount rate would add an $823 million charge on the remaining Peripheral Vascular goodwill.
Earnings
CEO Kevin Lobo calls the CMR Surgical deal "a high risk kind of a deal" as Stryker cuts its 2026 outlook on its last call before he exits.
Earnings
CEO Kevin Lobo, on his last call in the job, said a weaker market and distracted sales teams left Stryker short of its own expectations.
Earnings
The medical device maker's reported EPS fell 11.7% to $1.96 on a $293 million goodwill impairment, and it added $3.0 billion to its buyback.
SEC Filings
Kevin Lobo becomes Executive Chair on January 1, 2027, keeping his pay terms but losing eligibility for new stock awards.